AstraZeneca Updates Digital Lifestyle Program to Include CV Health
While the online tools makes clear consumers can use it without obligation, the therapy section give patients information on AstraZeneca products.
The role of digital health technology in managing chronic disease continues to expand, with companies vying for everything from tracking people’s steps to offering the evidence-based National Diabetes Prevention Program (DPP).
The pharmaceutical maker AstraZeneca, whose treatments include dapagliflozin (Farxiga) for diabetes and rosuvastatin (Crestor) to lower cholesterol, joined the fray in 2014 with
With the
While the online program makes clear that consumers can use the material without obligation, part of the
The upgrade includes a new feature, Fit My Fridge, which helps users prepare healthy meals with ingredients they already have at home, offering help for busy professionals who cannot plan for every meal. More than 10,000 recipes based on guidelines from the American Diabetes Association and American Heart Association are available. The online program is available in mobile formats, the statement said.
Adding a cardiovascular element will “differentiate” Fit2Me from other online programs, according to the statement, making it “one of the only health management tools that allows people to create a customized diet and exercise plan based on food and exercise preferences, as well as health challenge areas.”
“People living with cardiovascular disease frequently deal with a wide range of risk factors that impact everyday health but, importantly, many of these risk factors are modifiable,” said William E. Boden, MD, Scientific Director, Clinical Trials Network, VA Boston Healthcare System. Having a free program like Fit2Me helps people with diabetes or other chronic conditions create sustainable lifestyle changes, he said.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Related Articles
- Metabolic Issues More Common in Patients With HIV
September 18th 2025
- Barriers to Gender-Affirming Surgery Persist Despite High Satisfaction Rate
September 18th 2025
- Eating Behaviors May Predict GLP-1 Therapy Success in Type 2 Diabetes
September 18th 2025